Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration

2010 ◽  
Vol 106 (9) ◽  
pp. 1332-1338 ◽  
Author(s):  
Christopher R. Chapple ◽  
Sender Herschorn ◽  
Paul Abrams ◽  
Joseph T. Wang ◽  
Marina Brodsky ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Prostate Specific Antigen ◽  
Extended Release ◽  
Specific Antigen ◽  
Efficacy And Safety ◽  
Antigen Concentration ◽  
Overactive Bladder Symptoms ◽  
Bladder Symptoms

scholarly journals Efficacy and safety of fesoterodine treatment for overactive bladder symptoms in elderly women with and without hypertension

2017 ◽  
Vol 25 (3) ◽  
pp. 251-257 ◽  
Author(s):  
Osamu Yokoyama ◽  
Hidetomi Yamagami ◽  
Shintaro Hiro ◽  
Shinichi Hotta ◽  
Masaki Yoshida
Keyword(s):  
Overactive Bladder ◽  
Elderly Women ◽  
Efficacy And Safety ◽  
Overactive Bladder Symptoms ◽  
Bladder Symptoms

Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms

2008 ◽  
Vol 24 (12) ◽  
pp. 3513-3521 ◽  
Author(s):  
Sender Herschorn ◽  
John Heesakkers ◽  
David Castro-Diaz ◽  
Joseph T. Wang ◽  
Marina Brodsky ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Extended Release ◽  
Patient Perception ◽  
Overactive Bladder Symptoms ◽  
Bladder Symptoms ◽  
Bladder Condition

scholarly journals Efficacy and Safety of Flexible Dose Fesoterodine in Men and Women with Overactive Bladder Symptoms Including Nocturnal Urinary Urgency

2013 ◽  
Vol 189 (4) ◽  
pp. 1396-1401 ◽  
Author(s):  
Jeffrey P. Weiss ◽  
Zhanna Jumadilova ◽  
Theodore M. Johnson ◽  
Mary P. FitzGerald ◽  
Martin Carlsson ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Urinary Urgency ◽  
Efficacy And Safety ◽  
Men And Women ◽  
Overactive Bladder Symptoms ◽  
Bladder Symptoms ◽  
Flexible Dose
Sign in / Sign up

Export Citation Format

Share Document